Mycobacterium tuberculosis 10-kDa co-chaperonin regulates the expression levels of receptor activator of nuclear factor-κB ligand and osteoprotegerin in human osteoblasts

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 3, 2015-01 ,pp. : 919-924

Spandidos Publications

Access to resources Recommend Favorite

Receptor Activator of Nuclear Factor-B Ligand (RANKL) Expression in Hepatocellular Carcinoma With Bone Metastasis

By Sasaki Atsushi   Ishikawa Kenji   Haraguchi Naotsugu   Inoue Hiroshi   Ishio Tetsuya   Shibata Kohei   Ohta Masayuki   Kitano Seigo   Mori Masaki  

Annals of Surgical Oncology, Vol. 14, Iss. 3, 2007-03 ,pp. : 1191-1199

Springer Publishing Company

Access to resources Recommend Favorite

Recombinant receptor activator of nuclear factor κB exhibits more marked inhibitory effects on osteoclasts compared with recombinant osteoprotegerin in vitro and in vivo

By          

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 631-638

Spandidos Publications

Access to resources Recommend Favorite

Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (Review)

By    

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3212-3218

Spandidos Publications

Access to resources Recommend Favorite

Amiloride inhibits osteoclastogenesis by suppressing nuclear factor-κB and mitogen-activated protein kinase activity in receptor activator of nuclear factor-κB-induced RAW264.7 cells

By                

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3451-3456

Spandidos Publications

Access to resources Recommend Favorite